Milestone Pharmaceuticals Inc.
MIST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001408443
No open-market purchases or sales by Milestone Pharmaceuticals Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $66.4M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Milestone Pharmaceuticals Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- −1 vs. Q2 2021
- Shares held
- 20.0M
- −192.9K (−1.0%) vs. Q2 2021
- Total value
- $113.9M
- +$3.13M (+2.8%) vs. Q2 2021
- New holders
- 2
- 4 more added
- Sold out
- 3
- 11 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MIST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 78 | $66.4M |
| Q1 2026 | 87 | $47.2M |
| Q4 2025 | 80 | $70.7M |
| Q3 2025 | 61 | $68.3M |
| Q2 2025 | 43 | $22.9M |
| Q1 2025 | 43 | $9.46M |
| Q4 2024 | 47 | $57.9M |
| Q3 2024 | 43 | $43.6M |
| Q2 2024 | 40 | $39.9M |
| Q1 2024 | 43 | $56.4M |
| Q4 2023 | 40 | $29.7M |
| Q3 2023 | 39 | $60.7M |
| Q2 2023 | 48 | $59.0M |
| Q1 2023 | 50 | $85.5M |
| Q4 2022 | 56 | $96.9M |
| Q3 2022 | 47 | $198.7M |
| Q2 2022 | 29 | $127.2M |
| Q1 2022 | 28 | $135.1M |
| Q4 2021 | 28 | $132.6M |
| Q3 2021 | 27 | $113.9M |
| Q2 2021 | 28 | $110.8M |
| Q1 2021 | 34 | $117.4M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Milestone Pharmaceuticals Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Carroll Financial Associates, Inc. | 40 | $0 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 147 | $1.00K | 0.00% | −1,419−90.6% | Reduced |
| Proequities, Inc. | 245 | $1.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,811 | $10.0K | 0.00% | +339+23.0% | Added |
| Acadian Asset Management LLC | 7,596 | $42.0K | 0.00% | −4,473−37.1% | Reduced |
| Federation des caisses Desjardins du Quebec | 10,500 | $60.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 10,466 | $60.0K | 0.00% | +10,466 | New |
| Goldman Sachs Group Inc | 12,004 | $69.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 17,576 | $100.0K | 0.00% | −3,283−15.7% | Reduced |
| State Street Corp | 20,448 | $117.0K | 0.00% | +3,822+23.0% | Added |
| Royal Bank of Canada | 26,195 | $149.0K | 0.00% | +25,996+13,063.3% | Added |
| Renaissance Technologies LLC | 26,400 | $151.0K | 0.00% | −81,154−75.5% | Reduced |
| Susquehanna Fundamental Investments, LLC | 39,802 | $227.0K | 0.00% | −11,700−22.7% | Reduced |
| Dimensional Fund Advisors LP | 45,517 | $260.0K | 0.00% | −1,683−3.6% | Reduced |
| Eversept Partners, LP | 113,597 | $648.6K | 0.05% | +113,597 | New |
| Boothbay Fund Management, LLC | 174,463 | $996.0K | 0.04% | −50,295−22.4% | Reduced |
| Barclays PLC | 200,688 | $1.15M | 0.00% | −3,213−1.6% | Reduced |
| Millennium Management LLC | 695,241 | $3.97M | 0.01% | −23,389−3.3% | Reduced |
| Pura Vida Investments, LLC | 850,312 | $4.86M | 0.37% | +147,767+21.0% | Added |
| Suvretta Capital Management, LLC | 851,291 | $4.86M | 0.08% | 00.0% | Unchanged |
| Morgan Stanley | 853,562 | $4.87M | 0.00% | −31,637−3.6% | Reduced |
| Ikarian Capital, LLC | 1,750,043 | $9.99M | 2.29% | −230,357−11.6% | Reduced |
| Ra Capital Management, L.P. | 2,246,503 | $12.8M | 0.18% | 00.0% | Unchanged |
| Novo Holdings A/S | 2,530,585 | $14.4M | 0.75% | 00.0% | Unchanged |
| Boxer Capital, LLC | 2,572,194 | $14.7M | 0.51% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 2,583,821 | $14.8M | 0.16% | 00.0% | Unchanged |
| RTW Investments, LP | 4,315,102 | $24.6M | 0.37% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −35,600−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −16,235−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −483−100.0% | Sold out |